Timber Pharmaceuticals, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
75.00
|
|
Average Rating
|
4.00
|
|
# Strong Buys
|
0
|
|
# Buys
|
1
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-12-31
|
-0.06
|
-2.41
|
-2.35
|
-3916.67%
|
|
2022-09-30
|
-0.05
|
-1.52
|
-1.47
|
-2940.00%
|
|
2022-06-30
|
-2.00
|
-7.50
|
-5.50
|
-275.00%
|
|
2022-03-31
|
-2.00
|
-2.50
|
-0.50
|
-25.00%
|
|
2021-12-31
|
-0.05
|
-0.05
|
0.00
|
0.00%
|
|
2021-09-30
|
-0.06
|
-1.34
|
-1.28
|
-2133.33%
|
|
2021-06-30
|
-0.84
|
-1.34
|
-0.50
|
-59.52%
|
|
2021-03-31
|
-0.60
|
-0.05
|
0.55
|
91.67%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-13.93
|
|
2021-12-31
|
-2.78
|
|
2020-12-31
|
-2.64
|
|
2019-12-31
|
-9.91
|
|
2018-12-31
|
-20.25
|
|
2016-12-31
|
-0.59
|
|
2015-12-31
|
-0.42
|
|
2014-12-31
|
-6958.99
|